Close this search box.

10 years Pivot Park: Innatoss

Despite millions of people being affected by infectious diseases annually, there is little scientific interest in this field. Innatoss aims to fill the gap by contributing to the development of reliable and affordable diagnostics.

If there is not yet a good test for DIAGNOSIS of a certain disease, we will develop it ourselves

“Infectious diseases have a long course and are often difficult to diagnose. It’s not commercially viable for large companies in the diagnostic industry to develop good diagnostic techniques for minor outbreaks and individual cases. Only when there’s a major epidemic or pandemic, affordable diagnostics are developed,” according to Anja Garritsen, founder and CEO of Innatoss Laboratories.

Innatoss is an SME focusing on Lyme disease, Q fever and more recently on COVID-19. Anja believes it’s essential that more attention is paid to infectious diseases, and targeted diagnostics specifically.

The consequences of infection for individual patients can be life-changing. “Infectious diseases are often underestimated and there are a lot of them. Just step into your garden, and you’re at risk. The symptoms are often non-characteristic, unclear and similar to other health issues.”

Misdiagnoses and underreporting are common problems with infectious diseases. “For example, the first Q-fever patients with long term complaints were simply sent home. Extreme fatigue, exhaustion, headaches, shortness of breath were reported as psychosomatic problems. But Q fever is a really dangerous disease that can have serious long term consequences. Only when a number of patients with the similar symptoms visited the same GP it was attributed to more than a coincidence.” Garritsen hopes that as a result of the COVID pandemic, people will become far more alert to infectious diseases and family doctors recognise the symptoms faster so treatment can begin in time.

Innatoss has chosen to work on the infectious diseases that receive a lot of media attention, but where diagnosis and treatment are lagging behind. Garritsen said, “We see opportunities here to use immunological tests to improve diagnostics. We have been investing time and research into this since 2012. We are examining whether we can use existing tests for other diseases. For example, research into T cells to determine a specific infection. If there is not yet a good test for diagnosis of a certain disease, we will develop it ourselves.

“We don’t just develop those tests, we also perform the testing ourselves in our accredited laboratory. Therefore we can actively contribute to reducing the array of health problems associated with Lyme disease, COVID-19 and Q fever. These are often regarded as an occupational hazards but can be highly debilitating so it’s almost a social responsibility to combat them!” A perfect example of Innatoss’ working methodology is their collaboration with Water Authorities, green keepers and ecological organizations. Once a year they perform a test for Lyme disease for all employees at risk. “We all benefit. Previous undetected infections are detected which can be a huge help to individuals and organisations, while Innatoss has access to the research data, which helps us help society in general.”

Although Innatoss is a relatively small laboratory, it has big ambitions. Garritsen, who started her career in 1993 with a postdoc at Organon, took the big step in 2012 to start her own business at Pivot Park. From a one-woman company, Innatoss quickly grew into a company where a close-knit team of eleven professionals with extensive experience in the pharmaceutical and diagnostic industry works to increase Pandemic Preparedness. 

Innatoss is a diagnostic laboratory specialising in infectious diseases such as Lyme disease, Q fever and since 2020, COVID-19. Innatoss is pushing the boundaries of diagnostics by making innovative use of existing tests. If no such tests exist then Innatoss will develop them. The laboratory regularly supports and assists leading organisations in addressing infectious diseases in the work place.


Are you ready to make your mark and improve global health together as an innovator or as a service provider in the park? Join our community

Pivot Park Captains' Dinner

10 years ago, Pivot Park opened its doors to the world. Thanks to your commitment, support and confidence, we have been able to grow it into the successful and innovative biopharmaceutical campus it is today.

Now it’s time to celebrate!

We are therefore delighted to invite you – along with all your fellow CEOs at Pivot Park – to a special night out featuring inspiring art, a wonderful dinner and lots of opportunities to network and exchange ideas.

Erwin Wurm | Am I a House?

For the first time, the artist shows a cross-section of his work, from Narrow Furniture to One Minute Sculptures, within the walls of a historic building. Villa Constance, a former home that today houses Museum Jan Cunen, is not only a location but also part of the conversation. Because what exactly is a house?


The development of medicines in Oss began one hundred years ago. It was then that the foundations were laid for what would become a flourishing pharmaceutical sector in the Netherlands, leading to groundbreaking discoveries such as insulin and the anti-conception pill.

Today, the entire chain is still represented in Oss, from early-stage research to the commercial scale production of medicines. Working in Oss, we focus on the health of people all over the world. Employees at dozens of companies large and small put their heart and soul into new medicines, products and services that will improve lives worldwide. Together, our strength lies in our combination of broad knowledge about the development of medicines and a thorough understanding of the requirements of high-quality production.

This shared past and common values stimulate strong bonds among everyone who works in pharmaceuticals in Oss. We build on qualities, expertise and networks that go back decades. And with a wide variety of pharmaceutical companies, suppliers and scientific institutions all located nearby, we offer an attractive business climate and an excellent basis for international collaboration.

We are proud to work together to create a better and healthier future for all, a collaboration that in turn fuels growing employment: today, most pharmaceutical jobs in the Netherlands are in Oss. Here we connect talent and companies and stimulate entrepreneurship, while our expert employees are our most important asset. Their drive ensures that Oss has an influence on health all over the world.

Pharma in Oss offers endless opportunities to startups and talent in a city and region that is a joy to live and work in. We are committed to collaboration and sustainable and successful entrepreneurship. Oss’s pharmaceutical companies are intrinsically competitive while also being committed to quality and safety. This, plus their focus on new health solutions and contemporary technology, makes us a leader in our pursuit of a better life for people worldwide.